This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kennedy, J. Articles by Buchan, A.M. Search for Related Content PubMed PubMed Citation Articles by Kennedy, J. Articles by Buchan, A.M.

(Stroke. 2004;35:360.)
© 2004 American Heart Association, Inc.

Advances in Stroke 2003

Acute Neurovascular Syndromes: Hurry Up, Please, It’s Time¹

J. Kennedy, MB, MSc, MRCP A.M. Buchan, MD, FRCP

From the Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Canada.

Correspondence to Dr A.M. Buchan, Stroke Research Office, Room 1162, Foothills Medical Centre, 1403 29th St NW, Calgary, Alberta, Canada T2N 2T9. E-mail abuchan@ucalgary.ca

Key Words: Advances in Stroke • cerebral ischemia, transient • diagnosis • stroke

An extract of the first 250 words of the full text is provided, because this article has no abstract.

A Brief History of Time

"It isn’t that they can’t see the solution. It is that they can’t see the problem."²

Less than 20 years ago, the most common cited reason for the admission of a patient with stroke to hospital was for nursing or general nonmedical care.³ Admission to make or confirm the diagnosis or for medical treatment were mentioned less than half as often. In the same study, the most common reasons for patients remaining in the community were that they had suffered a minor stroke or services were available in the community for assessment and work-up. The evidence surrounding the benefit of aspirin in acute stroke, the reduction of death and dependence with admission of patients to dedicated stroke units, and perhaps most controversially, the demonstration of the efficacy of thrombolysis, by either intravenous or intra-arterial routes, in reducing disability following acute ischemic stroke had yet to appear.^4,5

This article does not seek to re-examine the debate surrounding the use of thrombolysis in acute ischemic stroke. This has been explored at length elsewhere.^6–8 The aim of this article is to explore the new perspective on the treatment of hyperacute cerebral ischemia that has arisen because of the increasing use of tissue plasminogen activator (tPA), in particular the influence of time.

The organization of acute stroke services is now required to be time sensitive to ensure that the maximum number of patients eligible for thrombolysis have the greatest chance of a good neurological outcome as possible.⁹ As a result, patients are presenting sooner, . . . [Full Text of this Article]